Cyclobarbital

Last updated
Cyclobarbital
Cyclobarbital.svg
Cyclobarbital ball-and-stick.png
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral (tablets)
ATC code
Legal status
Legal status
Pharmacokinetic data
Metabolism Hepatic
Excretion Renal
Identifiers
  • 5-(1-cyclohexenyl)-5-ethyl-1,3-diazinane-2,4,6-trione
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.000.127 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C12H16N2O3
Molar mass 236.271 g·mol−1
3D model (JSmol)
  • O=C1NC(=O)NC(=O)C1(/C2=C/CCCC2)CC
  • InChI=1S/C12H16N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h6H,2-5,7H2,1H3,(H2,13,14,15,16,17) Yes check.svgY
  • Key:WTYGAUXICFETTC-UHFFFAOYSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Cyclobarbital, cyclobarbitol or cyclobarbitone refers to a barbiturate derivative developed in the early 1970s in the Soviet Union. [2]

It was available in Russia until 2019, marketed and distributed as Reladorm, a fixed-dose combination pairing 100 mg cyclobarbital and 10 mg diazepam (a benzodiazepine anxiolytic, muscle relaxant, and anticonvulsant) indicated for treating insomnia before it was discontinued in 2019.

References

  1. Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. Breimer DD, Winten MA (March 1976). "Pharmacokinetics and relative bioavailability of cyclobarbital calcium in man after oral administration". European Journal of Clinical Pharmacology. 09 (5–6): 443–50. doi:10.1007/bf00606563. PMID   989475. S2CID   20271169.